A novel STAT3 inhibitor (rR9-GRIM19) markedly enhances antitumor effects by Treg suppression when combined with Th1-type immunotherapy in melanoma-bearing mice

被引：0

|

作者：

Okamoto, T. ^{[1
]}

Shibagaki, N. ^{[1
]}

Hanawa, F. ^{[1
]}

Shimada, S. ^{[1
]}

机构：

[1] Univ Yamanashi, Dept Dermatol, Yamanashi, Japan

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2011年 / 131卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

560

引用

收藏

页码：S94 / S94

页数：1

相关论文

共 1 条

[1] Complete B16 melanoma regression with Trp2-specific CTL expansion is elicited by intratumoral injections of a novel STAT3 inhibitor (rR9-GRIM19) plus Tc1/Th1 inducers without melanoma-specific immunotherapy
Hanawa, F.
Shibagaki, N.
Okamoto, T.
Shimada, S.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S2 - S2